Healthcare provider profile · identity verified

Anthony Scott Rogers, MD

Family Practice · ANGLETON, TX · NPI 1780667295

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	372	117
Amlodipine Besylate	Amlodipine Besylate	349	95
Levothyroxine Sodium	Levothyroxine Sodium	345	90
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	336	52
Alprazolam	Alprazolam	323	54
Gabapentin	Gabapentin	268	61
Lisinopril	Lisinopril	220	65
Losartan Potassium	Losartan Potassium	217	60
Metoprolol Succinate	Metoprolol Succinate	203	54
Omeprazole	Omeprazole	190	59
Metformin Hcl	Metformin Hcl	168	50
Hydrochlorothiazide	Hydrochlorothiazide	163	42
Pantoprazole Sodium	Pantoprazole Sodium	158	36
Escitalopram Oxalate	Escitalopram Oxalate	150	38
Zolpidem Tartrate	Zolpidem Tartrate	141	30
Tramadol Hcl	Tramadol Hcl	132	32
Pravastatin Sodium	Pravastatin Sodium	123	29
Tamsulosin Hcl	Tamsulosin Hcl	121	31
Rosuvastatin Calcium	Rosuvastatin Calcium	119	33
Glimepiride	Glimepiride	118	32
Metoprolol Tartrate	Metoprolol Tartrate	117	32
Albuterol Sulfate Hfa	Albuterol Sulfate	114	39
Clonazepam	Clonazepam	108	19
Ozempic	Semaglutide	108	20
Diclofenac Sodium	Diclofenac Sodium	106	34
Tizanidine Hcl	Tizanidine Hcl	106	21
Allopurinol	Allopurinol	101	25
Duloxetine Hcl	Duloxetine Hcl	98	21
Meloxicam	Meloxicam	97	32
Potassium Chloride	Potassium Chloride	96	27
Trazodone Hcl	Trazodone Hcl	96	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	91	27
Furosemide	Furosemide	90	33
Metformin Hcl Er	Metformin Hcl	90	28
Atenolol	Atenolol	85	20
Montelukast Sodium	Montelukast Sodium	84	26
Clopidogrel	Clopidogrel Bisulfate	81	20
Simvastatin	Simvastatin	80	20
Cefuroxime	Cefuroxime Axetil	75	55
Carvedilol	Carvedilol	73	22
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	68	suppressed
Prednisone	Prednisone	66	51
Aripiprazole	Aripiprazole	59	12
Amoxicillin	Amoxicillin	58	38
Methocarbamol	Methocarbamol	55	17
Azithromycin	Azithromycin	51	46
Eliquis	Apixaban	51	15
Lovastatin	Lovastatin	51	15
Olmesartan Medoxomil	Olmesartan Medoxomil	47	11
Ibuprofen	Ibuprofen	46	15
Januvia	Sitagliptin Phosphate	45	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	12
Citalopram Hbr	Citalopram Hydrobromide	43	14
Acetaminophen-Codeine	Acetaminophen With Codeine	42	12
Mounjaro	Tirzepatide	42	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	31
Fluoxetine Hcl	Fluoxetine Hcl	41	suppressed
Ezetimibe	Ezetimibe	40	13
Fluticasone Propionate	Fluticasone Propionate	40	14
Ropinirole Hcl	Ropinirole Hcl	40	suppressed
Jardiance	Empagliflozin	39	11
Celecoxib	Celecoxib	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	35	20
Diazepam	Diazepam	35	suppressed
Famotidine	Famotidine	35	12
Methylprednisolone	Methylprednisolone	35	33
Finasteride	Finasteride	34	suppressed
Fluconazole	Fluconazole	34	suppressed
Spironolactone	Spironolactone	33	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	33	suppressed
Buspirone Hcl	Buspirone Hcl	31	suppressed
Ondansetron Odt	Ondansetron	31	11
Trulicity	Dulaglutide	31	suppressed
Sertraline Hcl	Sertraline Hcl	30	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	29	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	28	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	28	25
Pioglitazone Hcl	Pioglitazone Hcl	28	suppressed
Hydralazine Hcl	Hydralazine Hcl	27	suppressed
Zolpidem Tartrate Er	Zolpidem Tartrate	27	suppressed
Carisoprodol	Carisoprodol	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Temazepam	Temazepam	26	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	25	11
Esomeprazole Magnesium	Esomeprazole Magnesium	24	suppressed
Lorazepam	Lorazepam	24	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	24	suppressed
Valacyclovir	Valacyclovir Hcl	24	12
Azelastine Hcl	Azelastine Hcl	23	suppressed
Glipizide	Glipizide	23	suppressed
Mirtazapine	Mirtazapine	23	suppressed
Xarelto	Rivaroxaban	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	22	12
Hydrocortisone	Hydrocortisone	22	17
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Ibandronate Sodium	Ibandronate Sodium	22	suppressed
Ketoconazole	Ketoconazole	22	suppressed
Symbicort	Budesonide/Formoterol Fumarate	22	suppressed
Farxiga	Dapagliflozin Propanediol	21	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Nystatin	Nystatin	21	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	20	suppressed
Bupropion Xl	Bupropion Hcl	19	suppressed
Cephalexin	Cephalexin	18	11
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Pregabalin	Pregabalin	18	suppressed
Benazepril Hcl	Benazepril Hcl	17	suppressed
Glipizide Er	Glipizide	17	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	17	suppressed
Baclofen	Baclofen	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Valsartan	Valsartan	16	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	15	suppressed
Cefadroxil	Cefadroxil	15	14
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	15	suppressed
Fluocinonide	Fluocinonide	15	suppressed
Bydureon Bcise	Exenatide Microspheres	14	suppressed
Eszopiclone	Eszopiclone	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	14	suppressed
Topiramate	Topiramate	14	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	13	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	13	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	13	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Nabumetone	Nabumetone	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Propranolol Hcl	Propranolol Hcl	13	suppressed
Ramipril	Ramipril	13	suppressed
Synthroid	Levothyroxine Sodium	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Fentanyl	Fentanyl	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Primidone	Primidone	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Terbinafine Hcl	Terbinafine Hcl	12	suppressed
Acyclovir	Acyclovir	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Famciclovir	Famciclovir	11	suppressed
Indapamide	Indapamide	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	11	11
Premarin	Estrogens, Conjugated	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error